Featured Genetic Counselors Articles on HCP

SMA HCP News November Round-up: Risdiplam, Early Treatment, NURTURE Study

SMA HCP News November Round-up: Risdiplam, Early Treatment, NURTURE Study

While the biggest news this week may be the success of the drug risdiplam in improving motor function in a late stage clinical trial on patients with SMA types 2 and 3,1 other important data on SMA have also been published in recent weeks. Below is a roundup of new...

Spinal Muscular Atrophy: Mid-October 2019 Roundup

Spinal Muscular Atrophy: Mid-October 2019 Roundup

The beginning of fall has seen a steady stream of new data elucidating SMA mechanisms, as well as options for managing and treating the disease. There have also been reports of evolving efforts to optimize both SMA research and clinical care, such as through a new SMA...

Spinal Muscular Atrophy: Late-September 2019 Roundup

Spinal Muscular Atrophy: Late-September 2019 Roundup

Summer has closed with new data and news on SMA coming to the fore. Much of the research on SMA published in recent weeks has focused on how to best treat the disease, and some new debate has emerged surrounding the relative advantages of Zolgensma versus Spinraza. At...

Spinal Muscular Atrophy: June Bi-Monthly Roundup

Spinal Muscular Atrophy: June Bi-Monthly Roundup

Since our last roundup, there has been continued focus in the spinal muscular atrophy (SMA) literature how best to treat the disease. There also continues to be research geared toward understanding the biology of the disease, as well as on SMA management, what it is...

Genetic Counselors Related SMA Resources

Latest Posts from SMA News Today

Recent SMA Genetic Counselor News

RSS feed from SMA News Today

Genetic Counselors Related Forum Topics

RSS feed from SMA News Today

Subscribe to our mailing list

* indicates required
Privacy Policy
Email Format
Please select all the ways you would like to hear from BioNews Services, LLC:
You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.
We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.